financetom
Business
financetom
/
Business
/
Dropbox Insider Sold Shares Worth $1,922,334, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dropbox Insider Sold Shares Worth $1,922,334, According to a Recent SEC Filing
May 3, 2024 2:54 PM

05:17 PM EDT, 05/03/2024 (MT Newswires) -- Andrew Houston, 10% Owner, Director, Chief Executive Officer, on May 01, 2024, sold 82,000 shares in Dropbox ( DBX ) for $1,922,334. Following the Form 4 filing with the SEC, Houston has control over a total of 9,427,838 shares of the company, with 8,266,666 shares held directly and 1,161,172 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1467623/000156218024003808/xslF345X03/primarydocument.xml

Price: 23.31, Change: -0.06, Percent Change: -0.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Jun 5, 2025
Alvotech ( ALVO ) on Thursday collaborated with Dr. Reddy's Laboratories Ltd. to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets. Merck & Co Inc's ( MRK ) Keytruda (pembrolizumab) is indicated for numerous cancer types. Keytruda's worldwide sales were $29.5 billion in 2024. The collaboration combines Dr. Reddy's and Alvotech's ( ALVO ) capabilities...
IMPACT Silver Closes $5.2 Million Non-Brokered Private Placement Financing
IMPACT Silver Closes $5.2 Million Non-Brokered Private Placement Financing
Jun 5, 2025
01:55 PM EDT, 06/05/2025 (MT Newswires) -- IMPACT Silver ( ISVLF ) on Thursday said it closed a final tranche of a non-brokered private placement financing, initially announced on April 15 and subsequently increased on April 18, bringing the total oversubscribed financing to around $5.2 million, including the first tranche closing of approximately $3.9 million. The company said it received...
Update: K92 Mining Provides High-Grade Results From Drilling at Kainantu Gold Mine in Papua New Guinea
Update: K92 Mining Provides High-Grade Results From Drilling at Kainantu Gold Mine in Papua New Guinea
Jun 5, 2025
02:02 PM EDT, 06/05/2025 (MT Newswires) -- (Adds comment and updates shares.) K92 Mining ( KNTNF ) on Wednesday said it recorded multiple high-grade intersections with broadening widths at Kora's K2 Vein at the Kainantu Gold Mine in Papua New Guinea. The intersections with broadening widths, referred to as dilatant zones, are near existing mine infrastructure increasing the potential for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved